In Silico Clinical Trials Market Size, Share & Trends Analysis Report By Therapeutic Area (Oncology, Infectious Diseases), By Phase (Phase I, II, III), By Industry (Medical Devices, Pharmaceutical), And Segment Forecasts, 2022 - 2030

Table of Content

Chapter 1 Methodology and Scope
                   1.1 Market Segmentation & Scope
                       1.1.1 Industry
                       1.1.2 Therapeutic Area
                       1.1.3 Phase
                       1.1.4 Regional Scope
                       1.1.5 Estimates And Forecast Timeline
                   1.2 Research Methodology
                   1.3 Information Procurement
                       1.3.1 Purchased Database
                       1.3.2 Gvr’s Internal Database
                       1.3.3 Secondary Sources
                       1.3.4 Primary Research
                       1.3.5 Details Of Primary Research
                   1.4 Information or Data Analysis
                       1.4.1 Data Analysis Models
                   1.5 Market Formulation & Validation
                   1.6 Model Details
                       1.6.1 Commodity Flow Analysis (Model 1)
                   1.7 List of Secondary Sources
                   1.8 List of Primary Sources
                   1.9 List of Abbreviations
                   1.10 Objectives
                       1.10.1 Objective - 1: Understanding the market dynamics
                       1.10.2 Objective - 2: Understanding the market estimates and forecasts
                       1.10.3 Objective - 3: Understanding the attributes such as strategy framework
                       1.10.4 Objective - 4: Understanding the key service and application scopes to conclude on the market size
Chapter 2 Executive Summary
                   2.1 Market Outlook
Chapter 3 Insilico Clinical Trials Market : Variables, Trends, & Scope
                   3.1 Market Segmentation and Scope
                   3.2 Market Driver Analysis
                       3.2.1 Cost Efficiency Associated with Insilico Clinical
                           Trials Compared to Traditional Clinical Trials
                       3.2.2 Growing Trend of Eliminating/Reducing Animal
                           Testing
                       3.2.3 Increasing Technological Advancement in the
                           Insilico Clinical Trials Market
                   3.3 Market Restraint Analysis
                       3.3.1 Protein Flexibility Issues, Molecule
                           Conformation and Promiscuity May Hinder
                           Accurate Predictions, thus limiting its Adoption
                       3.3.2 Limited Awareness in the Developing
                           Economies
                   3.4 Penetration & Growth Prospect Mapping
                   3.5 Porter’s Five Forces Analysis
                   3.6 PESTEL Analysis
Chapter 4 Insilico Clinical Trials Market : Industry Segment Analysis
                   4.1 Insilico Clinical Trials : Market Share Analysis, 2021 & 2030
                   4.2 Medical devices
                       4.2.1 Medical devices market, 2018 - 2030 (USD Million)
                   4.3 Pharmaceutical
                       4.3.1 Pharmaceutical market, 2018 - 2030 (USD Million)
Chapter 5 Insilico Clinical Trials Market : Therapeutic Segment Analysis
                   5.1 Insilico Clinical Trials : Market Share Analysis, 2021 & 2030
                   5.2 Oncology
                       5.2.1 Oncology market, 2018 - 2030 (USD Million)
                   5.3 Infectious disease
                       5.3.1 Infectious disease market, 2018 - 2030 (USD Million)
                   5.4 Hematology
                       5.4.1 Hematology market, 2018 - 2030 (USD Million)
                   5.5 Cardiology
                       5.5.1 Cardiology market, 2018 - 2030 (USD Million)
                   5.6 Dermatology
                       5.6.1 Dermatology market, 2018 - 2030 (USD Million)
                   5.7 Neurology
                       5.7.1 Neurology market, 2018 - 2030 (USD Million)
                   5.8 Diabetes
                       5.8.1 Diabetes market, 2018 - 2030 (USD Million)
                   5.9 Others
                       5.9.1 Others market, 2018 - 2030 (USD Million)
Chapter 6 Insilico Clinical Trials Market: Phase Segment Analysis
                   6.1 Insilico Clinical Trials: Market Share Analysis, 2021 & 2030
                   6.2 Phase I
                       6.2.1 Phase I, 2018 - 2030 (USD Million)
                   6.3. Phase II
                       6.3.1 Phase II, 2018 - 2030 (USD Million)
                   6.4. Phase III
                       6.4.1 Phase III, 2018 - 2030 (USD Million)
                   6.5. Phase IV
                       6.5.1 Phase IV, 2018 - 2030 (USD Million)
Chapter 7 Insilico Clinical Trials Market : Region Segment Analysis
                   7.1 Insilico Clinical Trials : Market Share Analysis, 2021 & 2030
                   7.2 North America
                       7.2.1 North America in silico clinical trials market, 2018 - 2030 (USD Million)
                       7.2.2 U.S.
                           7.2.2.1 U.S. in silico clinical trials market, 2018 - 2030 (USD Million)
                       7.2.3 Canada
                           7.2.3.1 Canada in silico clinical trials market, 2018 - 2030 (USD Million)
                   7.3 Europe
                       7.3.1 Europe in silico clinical trials market, 2018 - 2030 (USD Million)
                       7.3.2 U.K.
                           7.3.2.1 U.K. in silico clinical trials market, 2018 - 2030 (USD Million)
                       7.3.3 Germany
                           7.3.3.1 Germany in silico clinical trials market, 2018 - 2030 (USD Million)
                       7.3.4 France
                           7.3.4.1 France in silico clinical trials market, 2018 - 2030 (USD Million)
                       7.3.5 Italy
                           7.3.5.1 Italy in silico clinical trials market, 2018 - 2030 (USD Million)
                       7.3.6 Spain
                           7.3.6.1 Spain in silico clinical trials market, 2018 - 2030 (USD Million)
                   7.4 Asia Pacific
                       7.4.1 Asia Pacific in silico clinical trials market, 2018 - 2030 (USD Million)
                       7.4.2 India
                           7.4.2.1 India in silico clinical trials market, 2018 - 2030 (USD Million)
                       7.4.3 China
                           7.4.3.1 China in silico clinical trials market, 2018 - 2030 (USD Million)
                       7.4.4 Japan
                           7.4.4.1 Japan in silico clinical trials market, 2018 - 2030 (USD Million)
                       7.4.5 Australia
                           7.4.5.1 Australia in silico clinical trials market, 2018 - 2030 (USD Million)
                       7.4.6 South Korea
                           7.4.6.1 South Korea in silico clinical trials market, 2018 - 2030 (USD Million)
                   7.5 Latin America
                       7.5.1 Latin America in silico clinical trials market, 2018 - 2030 (USD Million)
                       7.5.2 Brazil
                           7.5.2.1 Brazil in silico clinical trials market, 2018 - 2030 (USD Million)
                       7.5.3 Mexico
                           7.5.3.1 Mexico in silico clinical trials market, 2018 - 2030 (USD Million)
                       7.5.4 Argentina
                           7.5.4.1 Argentina in silico clinical trials market, 2018 - 2030 (USD Million)
                       7.5.5 Colombia
                           7.5.5.1 Colombia in silico clinical trials market, 2018 - 2030 (USD Million)
                   7.6 MEA
                       7.6.1 MEA in silico clinical trials market, 2018 - 2030 (USD Million)
                       7.6.2 South Africa
                           7.6.2.1 South Africa in silico clinical trials market, 2018 - 2030 (USD Million)
                       7.6.3 Saudi Arabia
                           7.6.3.1 Saudi Arabia in silico clinical trials market, 2018 - 2030 (USD Million)
                       7.6.4 UAE
                           7.6.4.1 UAE in silico clinical trials market, 2018 - 2030 (USD Million)
Chapter 8 Company Profiles
                   8.1 Certara, Inc.
                       8.1.1 Company overview
                       8.1.2 Financial performance
                       8.1.3 Service benchmarking
                       8.1.4 Strategic initiatives
                   8.2 Novadiscovery Sas
                       8.2.1 Company overview
                       8.2.2 Financial performance
                       8.2.3 Service benchmarking
                       8.2.4 strategic initiatives
                   8.3 Insilico Medicine, Inc.
                       8.3.1 Company overview
                       8.3.2 Service benchmarking
                       8.3.3 Strategic initiatives
                   8.4 Dassault Systemes SE
                       8.4.1 Company overview
                       8.4.2 Financial performance
                       8.4.3 Servcie benchmarking
                       8.4.4 Strategic initiatives
                   8.5 GNS Healthcare Inc .
                       8.5.1 Company overview
                       8.5.2 Financial performance
                       8.5.3 Service benchmarking
                       8.5.4 Strategic initiatives
                   8.6 The AnyLogic Company
                       8.6.1 Company overview
                       8.6.2 Financial performance
                       8.6.3 Service benchmarking
                       8.6.4 Strategic initiatives
                   8.7 InSilicoTrials
                       8.7.1 Company overview
                       8.7.2 Financial performance
                       8.7.3 Service benchmarking
                       8.7.4 Strategic initiatives
                   8.8 Immunetrics Inc.
                       8.8.1 Company overview
                       8.8.2 Financial performance
                       8.8.3 Service benchmarking
                       8.8.4 Strategic initiatives
                   8.9 Nuventra Pharma Sciences
                       8.9.1 Company overview
                       8.9.2 Service benchmarking
                       8.9.3 Strategic initiatives
                   8.10 Abzena Ltd.
                       8.10.1 Company overview
                       8.10.2 Service benchmarking
                       8.10.3 Strategic initiatives

List of Tables

Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Global In Silico Clinical Trials Market, by Region, 2018 - 2030 (USD Million)
Table 4 Global In Silico Clinical Trials Market, by Industry, 2018 - 2030 (USD Million)
Table 5 Global In Silico Clinical Trials Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 6 Global In Silico Clinical Trials Market, by Phase, 2018 - 2030 (USD Million)
Table 7 North America In Silico Clinical Trials Market, by Country, 2018 - 2030 (USD Million)
Table 8 North America In Silico Clinical Trials Market, by Industry, 2018 - 2030 (USD Million)
Table 9 North America In Silico Clinical Trials Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 10 North America In Silico Clinical Trials Market, by Phase, 2018 - 2030 (USD Million)
Table 11 U.S. In Silico Clinical Trials Market, by Industry, 2018 - 2030 (USD Million)
Table 12 U.S. In Silico Clinical Trials Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 13 U.S. In Silico Clinical Trials Market, by Phase, 2018 - 2030 (USD Million)
Table 14 Canada In Silico Clinical Trials Market, by Industry, 2018 - 2030 (USD Million)
Table 15 Canada In Silico Clinical Trials Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 16 Canada In Silico Clinical Trials Market, by Phase, 2018 - 2030 (USD Million)
Table 17 Europe In Silico Clinical Trials Market, by Country, 2018 - 2030 (USD Million)
Table 18 Europe In Silico Clinical Trials Market, by Industry, 2018 - 2030 (USD Million)
Table 19 Europe In Silico Clinical Trials Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 20 Europe In Silico Clinical Trials Market, by Phase, 2018 - 2030 (USD Million)
Table 21 U.K. In Silico Clinical Trials Market, by Industry, 2018 - 2030 (USD Million)
Table 22 U.K. In Silico Clinical Trials Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 23 U.K. In Silico Clinical Trials Market, by Phase, 2018 - 2030 (USD Million)
Table 24 Germany In Silico Clinical Trials Market, by Industry, 2018 - 2030 (USD Million)
Table 25 Germany In Silico Clinical Trials Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 26 Germany In Silico Clinical Trials Market, by Phase, 2018 - 2030 (USD Million)
Table 27 France In Silico Clinical Trials Market, by Industry, 2018 - 2030 (USD Million)
Table 28 France In Silico Clinical Trials Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 29 France In Silico Clinical Trials Market, by Phase, 2018 - 2030 (USD Million)
Table 30 Italy In Silico Clinical Trials Market, by Industry, 2018 - 2030 (USD Million)
Table 31 Italy In Silico Clinical Trials Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 32 Italy In Silico Clinical Trials Market, by Phase, 2018 - 2030 (USD Million)
Table 33 Spain In Silico Clinical Trials Market, by Industry, 2018 - 2030 (USD Million)
Table 34 Spain In Silico Clinical Trials Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 35 Spain In Silico Clinical Trials Market, by Phase, 2018 - 2030 (USD Million)
Table 36 Asia Pacific In Silico Clinical Trials Market, by Country, 2018 - 2030 (USD Million)
Table 37 Asia Pacific In Silico Clinical Trials Market, by Industry, 2018 - 2030 (USD Million)
Table 38 Asia Pacific In Silico Clinical Trials Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 39 Asia Pacific In Silico Clinical Trials Market, by Phase, 2018 - 2030 (USD Million)
Table 40 India In Silico Clinical Trials Market, by Industry, 2018 - 2030 (USD Million)
Table 41 India In Silico Clinical Trials Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 42 India In Silico Clinical Trials Market, by Phase, 2018 - 2030 (USD Million)
Table 43 China In Silico Clinical Trials Market, by Industry, 2018 - 2030 (USD Million)
Table 44 China In Silico Clinical Trials Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 45 China In Silico Clinical Trials Market, by Phase, 2018 - 2030 (USD Million)
Table 46 Japan In Silico Clinical Trials Market, by Industry, 2018 - 2030 (USD Million)
Table 47 Japan In Silico Clinical Trials Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 48 Japan In Silico Clinical Trials Market, by Phase, 2018 - 2030 (USD Million)
Table 49 Australia In Silico Clinical Trials Market, by Industry, 2018 - 2030 (USD Million)
Table 50 Australia In Silico Clinical Trials Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 51 Australia In Silico Clinical Trials Market, by Phase, 2018 - 2030 (USD Million)
Table 52 South Korea In Silico Clinical Trials Market, by Industry, 2018 - 2030 (USD Million)
Table 53 South Korea In Silico Clinical Trials Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 54 South Korea In Silico Clinical Trials Market, by Phase, 2018 - 2030 (USD Million)
Table 55 Latin America In Silico Clinical Trials Market, by Country, 2018 - 2030 (USD Million)
Table 56 Latin America In Silico Clinical Trials Market, by Industry, 2018 - 2030 (USD Million)
Table 57 Latin America In Silico Clinical Trials Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 58 Latin America In Silico Clinical Trials Market, by Phase, 2018 - 2030 (USD Million)
Table 59 Brazil In Silico Clinical Trials Market, by Industry, 2018 - 2030 (USD Million)
Table 60 Brazil In Silico Clinical Trials Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 61 Brazil In Silico Clinical Trials Market, by Phase, 2018 - 2030 (USD Million)
Table 62 Mexico In Silico Clinical Trials Market, by Industry, 2018 - 2030 (USD Million)
Table 63 Mexico In Silico Clinical Trials Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 64 Mexico In Silico Clinical Trials Market, by Phase, 2018 - 2030 (USD Million)
Table 65 Argentina In Silico Clinical Trials Market, by Industry, 2018 - 2030 (USD Million)
Table 66 Argentina In Silico Clinical Trials Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 67 Argentina In Silico Clinical Trials Market, by Phase, 2018 - 2030 (USD Million)
Table 68 Colombia In Silico Clinical Trials Market, by Industry, 2018 - 2030 (USD Million)
Table 69 Colombia In Silico Clinical Trials Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 70 Colombia In Silico Clinical Trials Market, by Phase, 2018 - 2030 (USD Million)
Table 71 MEA In Silico Clinical Trials Market, by Country, 2018 - 2030 (USD Million)
Table 72 MEA In Silico Clinical Trials Market, by Industry, 2018 - 2030 (USD Million)
Table 73 MEA In Silico Clinical Trials Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 74 MEA In Silico Clinical Trials Market, by Phase, 2018 - 2030 (USD Million)
Table 75 Saudi Arabia In Silico Clinical Trials Market, by Industry, 2018 - 2030 (USD Million)
Table 76 Saudi Arabia In Silico Clinical Trials Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 77 Saudi Arabia In Silico Clinical Trials Market, by Phase, 2018 - 2030 (USD Million)
Table 78 UAE In Silico Clinical Trials Market, by Industry, 2018 - 2030 (USD Million)
Table 79 UAE In Silico Clinical Trials Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 80 UAE In Silico Clinical Trials Market, by Phase, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Commodity Flow Analysis
Fig. 9 In silico Clinical Trials market snapshot (2021)
Fig. 10 In silico Clinical Trials market segmentation
Fig. 11 Market driver relevance analysis (Current & future impact)
Fig. 12 Market restraint relevance analysis (Current & future impact)
Fig. 13 Penetration & growth prospect mapping
Fig. 14 Porter’s five forces analysis
Fig. 15 SWOT analysis, by factor (political & legal, economic and technological)
Fig. 16 In silico Clinical Trials market industry outlook: Segment dashboard
Fig. 17 In silico Clinical Trials market: Industry movement analysis
Fig. 18 Medical Devices market 2018 - 2030 (USD Million)
Fig. 19 Pharmaceutical market 2018 - 2030 (USD Million)
Fig. 20 In silico Clinical Trials market therapeutic area outlook: Segment dashboard market 2018 - 2030 (USD Million)
Fig. 21 Oncology market 2018 - 2030 (USD Million)
Fig. 22 Infectious Disease market 2018 - 2030 (USD Million)
Fig. 23 Hematology market 2018 - 2030 (USD Million)
Fig. 24 Cardiology market 2018 - 2030 (USD Million)
Fig. 25 Dermatology market 2018 - 2030 (USD Million)
Fig. 26 Neurology market 2018 - 2030 (USD Million)
Fig. 27 Diabetes market 2018 - 2030 (USD Million)
Fig. 28 Others market 2018 - 2030 (USD Million)
Fig. 29 In silico Clinical Trials market Phase outlook: Segment dashboard market 2018 - 2030 (USD Million)
Fig. 30 Phase I market 2018 - 2030 (USD Million)
Fig. 31 Phase II market 2018 - 2030 (USD Million)
Fig. 32 Phase III market 2018 - 2030 (USD Million)
Fig. 33 Phase IV market 2018 - 2030 (USD Million)
Fig. 34 Regional market: Key takeaways
Fig. 35 Regional outlook, 2021 & 2030
Fig. 36 North America market 2018 - 2030 (USD Million)
Fig. 37 U.S. market 2018 - 2030 (USD Million)
Fig. 38 Canada market 2018 - 2030 (USD Million)
Fig. 39 Europe market 2018 - 2030 (USD Million)
Fig. 40 U.K. market 2018 - 2030 (USD Million)
Fig. 41 Germany market 2018 - 2030 (USD Million)
Fig. 42 France market 2018 - 2030 (USD Million)
Fig. 43 Italy market 2018 - 2030 (USD Million)
Fig. 44 Spain market 2018 - 2030 (USD Million)
Fig. 45 Asia Pacific market 2018 - 2030 (USD Million)
Fig. 46 India market 2018 - 2030 (USD Million)
Fig. 47 China market 2018 - 2030 (USD Million)
Fig. 48 Japan market 2018 - 2030 (USD Million)
Fig. 49 Australia market, 2018 - 2030 (USD Million)
Fig. 50 South Korea market, 2018 - 2030 (USD Million)
Fig. 51 Latin America market, 2018 - 2030 (USD Million)
Fig. 52 Brazil market, 2018 - 2030 (USD Million)
Fig. 53 Mexico market, 2018 - 2030 (USD Million)
Fig. 54 Argentina market, 2018 - 2030 (USD Million)
Fig. 55 Colombia market, 2018 - 2030 (USD Million)
Fig. 56 MEA market, 2018 - 2030 (USD Million)
Fig. 57 South Africa market, 2018 - 2030 (USD Million)
Fig. 58 Saudi Arabia market, 2018 - 2030 (USD Million)
Fig. 59 UAE market, 2018 - 2030 (USD Million)